Evidence-based guideline update: Steroids and antivirals for Bell palsy Report of the Guideline Development Subcommittee of the American Academy of Neurology

被引:126
作者
Gronseth, Gary S. [1 ]
Paduga, Remia [1 ]
机构
[1] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66103 USA
关键词
DOUBLE-BLIND; PREDNISOLONE; ACYCLOVIR; VALACYCLOVIR; MULTICENTER; MINNESOTA; ROCHESTER; PROGNOSIS; TRIAL;
D O I
10.1212/WNL.0b013e318275978c
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To review evidence published since the 2001 American Academy of Neurology (AAN) practice parameter regarding the effectiveness, safety, and tolerability of steroids and antiviral agents for Bell palsy. Methods: We searched Medline and the Cochrane Database of Controlled Clinical Trials for studies published since January 2000 that compared facial functional outcomes in patients with Bell palsy receiving steroids/antivirals with patients not receiving these medications. We graded each study (Class I-IV) using the AAN therapeutic classification of evidence scheme. We compared the proportion of patients recovering facial function in the treated group with the proportion of patients recovering facial function in the control group. Results: Nine studies published since June 2000 on patients with Bell palsy receiving steroids/antiviral agents were identified. Two of these studies were rated Class I because of high methodologic quality. Conclusions and Recommendations: For patients with new-onset Bell palsy, steroids are highly likely to be effective and should be offered to increase the probability of recovery of facial nerve function (2 Class I studies, Level A) (risk difference 12.8%-15%). For patients with new-onset Bell palsy, antiviral agents in combination with steroids do not increase the probability of facial functional recovery by >7%. Because of the possibility of a modest increase in recovery, patients might be offered antivirals (in addition to steroids) (Level C). Patients offered antivirals should be counseled that a benefit from antivirals has not been established, and, if there is a benefit, it is likely that it is modest at best. Neurology (R) 2012;79:2209-2213
引用
收藏
页码:2209 / 2213
页数:5
相关论文
共 48 条
  • [21] Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy Report of the American Epilepsy Society Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
    Kanner, Andres M.
    Ashman, Eric
    Gloss, David
    Harden, Cynthia
    Bourgeois, Blaise
    Bautista, Jocelyn F.
    Abou-Khalil, Bassel
    Burakgazi-Dalkilic, Evren
    Park, Esmeralda Llanas
    Stern, John
    Hirtz, Deborah
    Nespeca, Mark
    Gidal, Barry
    Faught, Edward
    French, Jacqueline
    EPILEPSY CURRENTS, 2018, 18 (04) : 269 - 278
  • [22] Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders Report of the Guideline Development Subcommittee of the American Academy of Neurology
    Koppel, Barbara S.
    Brust, John C. M.
    Fife, Terry
    Bronstein, Jeff
    Youssof, Sarah
    Gronseth, Gary
    Gloss, David
    NEUROLOGY, 2014, 82 (17) : 1556 - 1563
  • [23] Evidence-based Guideline: Treatment of Painful Diabetic Neuropathy Report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation
    Bril, Vera
    England, John
    Franklin, Gary M.
    Backonja, Miroslav
    Cohen, Jeffrey
    Del Toro, David
    Feldman, Eva
    Iverson, Donald J.
    Perkins, Bruce
    Russell, James W.
    Zochodne, Douglas
    PM&R, 2011, 3 (04) : 345 - 352
  • [24] Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society
    Kanner, Andres M.
    Ashman, Eric
    Gloss, David
    Harden, Cynthia
    Bourgeois, Blaise
    Bautista, Jocelyn F.
    Abou-Khalil, Bassel
    Burakgazi-Dalkilic, Evren
    Park, Esmeralda Llanas
    Stern, John
    Hirtz, Deborah
    Nespeca, Mark
    Gidal, Barry
    Faught, Edward
    French, Jacqueline
    NEUROLOGY, 2018, 91 (02) : 74 - 81
  • [25] EVIDENCE-BASED GUIDELINE: TREATMENT OF PAINFUL DIABETIC NEUROPATHY-REPORT OF THE AMERICAN ASSOCIATION OF NEUROMUSCULAR AND ELECTRODIAGNOSTIC MEDICINE, THE AMERICAN ACADEMY OF NEUROLOGY, AND THE AMERICAN ACADEMY OF PHYSICAL MEDICINE & REHABILITATION
    Bril, Vera
    England, John D.
    Franklin, Gary M.
    Backonja, Miroslav
    Cohen, Jeffrey A.
    Del Toro, David R.
    Feldman, Eva L.
    Iverson, Donald J.
    Perkins, Bruce
    Russell, James W.
    Zochodne, Douglas W.
    MUSCLE & NERVE, 2011, 43 (06) : 910 - 917
  • [26] Assessment: Symptomatic treatment for muscle cramps (an evidence-based review) Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
    Katzberg, Hans D.
    Khan, Ahmir H.
    So, Yuen T.
    NEUROLOGY, 2010, 74 (08) : 691 - 696
  • [27] Practice Parameter: Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
    Delgado, M. R.
    Hirtz, D.
    Aisen, M.
    Ashwal, S.
    Fehlings, D. L.
    McLaughlin, J.
    Morrison, L. A.
    Shrader, M. W.
    Tilton, A.
    Vargus-Adams, J.
    NEUROLOGY, 2010, 74 (04) : 336 - 343
  • [28] Evidence-based management of immune thrombocytopenia: ASH guideline update
    Neunert, Cindy E.
    Cooper, Nichola
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2018, : 568 - 575
  • [29] Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology
    Miller, R. G.
    Jackson, C. E.
    Kasarskis, E. J.
    England, J. D.
    Forshew, D.
    Johnston, W.
    Kalra, S.
    Katz, J. S.
    Mitsumoto, H.
    Rosenfeld, J.
    Shoesmith, C.
    Strong, M. J.
    Woolley, S. C.
    NEUROLOGY, 2009, 73 (15) : 1218 - 1226
  • [30] Celiac Disease: An Academy of Nutrition and Dietetics Evidence-Based Nutrition Practice Guideline
    Mcdermid, Joann M.
    Almond, M. Angie
    Roberts, Kristen M.
    Germer, Emily M.
    Geller, Marilyn G.
    Taylor, Theresa A.
    Sinley, Rachel C.
    Handu, Deepa
    JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS, 2023, 123 (12) : 1793 - +